QL47B (TFA)
QL47B TFA, a biotinylated analogue of QL47 , is a potent inhibitor of BTK, with an IC50 value of 1.3 μM. QL47B TFA has anti-tumor activity[1].
Product Specifications
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ql47b-tfa.html
Purity
98.32
Solubility
10 mM in DMSO
Smiles
O=C(O)C(F)(F)F.O=C1N(C2=C(C=C1)C=NC3=CC=C(C4=CN(C)N=C4)C=C32)C5=CC=C6C(N(C(/C=C/CNCCOCCOCCOCCNC(CCCC[C@H]7[C@](NC(N8)=O)([H])[C@]8([H])CS7)=O)=O)CC6)=C5
Molecular Formula
C48H56F3N9O9S
Molecular Weight
992.07
References & Citations
[1]Hong Wu, et al. Discovery of a Potent, Covalent BTK Inhibitor for B‑Cell Lymphoma. ACS Chem Biol. 2014 May 16;9 (5) :1086-91.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VD10N165 1 Each
Mouse Anti-Porcine ST6 Beta-Galactosamide Alpha-2,6-Sialyltranferase 1 (ST6GAL1) Monoclonal Antibody
Sign In for Pricing
View Details NBP2-73693MFV610 0.1 mL
Mouse Monoclonal PSMA7 Antibody (OTI3F11) [mFluor Violet 610 SE]
Sign In for Pricing
View Details 13672061 1.0 µg DNA
C10orf95 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details